GlaxoSmithKline Hints At Joining $10 Billion Auction For Pfizer Inc.'s OTC Unit
The drug group GlaxoSmithKline yesterday signalled its interest in bidding for Pfizer's over-the-counter health arm, set to go up for auction with a price of around $10bn (£5.75bn).